CREDITRISKMONITOR COM INC, 10-Q/A filed on 19 Aug 26
 | XBRL Documents
v3.26.1
Document And Entity Information - shares
 9 Months Ended
Sep. 30, 2025
Aug. 19, 2026
Document Information Line Items    
Entity Central Index Key 0000315958  
Document Type 10-Q/A  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2025  
Document Fiscal Year Focus 2025  
Document Transition Report false  
Entity File Number 1-8601  
Entity Registrant Name CreditRiskMonitor.com, Inc.  
Entity Incorporation, State or Country Code NV  
Entity Tax Identification Number 36-2972588  
City Area Code 845  
Local Phone Number 230-3000  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   10,767,501
Amendment Description As previously disclosed in the Company’s Current Report on Form 8-K filed with the SEC on August 6, 2026, the audit committee of the Company’s board of directors on August 3, 2026 concluded that (a) the Company’s previously issued unaudited condensed financial statements as of and for the quarterly periods ended (i) June 30, 2025, (ii) September 30, 2025 and 2024, and (iii) March 31, 2026 and 2025, and (b) the Company’s previously issued audited financial statements as of and for the fiscal years ended December 31, 2025 and 2024 (collectively, the “Affected Periods”), filed with the Securities and Exchange Commission (the “SEC”) in the respective Quarterly Reports on Form 10-Q for such quarterly periods and in the Annual Report on Form 10-K for such fiscal year and included in any reports, related earnings releases, or similar communications of the Company’s financial results, should no longer be relied upon and require restatement (the “Restatement”).  
Amendment Flag true  
Document Fiscal Period Focus Q3  
Current Fiscal Year End Date --12-31  
v3.26.1
CONDENSED BALANCE SHEETS - USD ($)
Sep. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 6,918,389 $ 6,674,473
Held-to-maturity securities 6,098,773 2,467,475
Accounts receivable, net of allowance for credit losses of $30,000 2,976,665 3,631,018
Other current assets 899,739 929,512
Total current assets 16,893,566 13,702,478
Held-to-maturity securities 6,481,000 8,758,000
Property and equipment, net 432,033 497,560
Operating lease right-of-use asset, net 105,777 0
Goodwill 1,954,460 1,954,460
Total assets 25,866,836 24,912,498
Current liabilities:    
Unexpired subscription revenue 10,894,478 10,886,860
Accounts payable 191,625 319,717
Operating lease liability, current portion 30,024 0
Accrued expenses 3,724,456 3,191,519
Total current liabilities 14,840,583 14,398,096
Deferred taxes on income, net 207,308 207,308
Unexpired subscription revenue, less current portion 164,508 151,474
Operating lease liability, less current portion 75,753 0
Total liabilities 15,288,152 14,756,878
Stockholders’ equity:    
Preferred stock, $.01 par value; authorized 5,000,000 shares; none issued 0 0
Common stock, $.01 par value; authorized 32,500,000 shares; issued and outstanding 10,767,501 and 10,722,401 shares, respectively 107,675 107,224
Additional paid-in capital 30,276,443 30,106,731
Accumulated deficit (19,805,434) (20,058,335)
Total stockholders’ equity 10,578,684 10,155,620
Total liabilities and stockholders’ equity $ 25,866,836 $ 24,912,498
v3.26.1
CONDENSED BALANCE SHEETS (Parentheticals) - USD ($)
Sep. 30, 2025
Dec. 31, 2024
CONDENSED BALANCE SHEETS [Abstract]    
Accounts receivable, allowance $ 30,000 $ 30,000
Preferred stock, par value (in Dollars per share) $ 0.01 $ 0.01
Preferred stock, authorized (in Shares) 5,000,000 5,000,000
Preferred stock, issued (in Shares) 0 0
Common stock, par value (in Dollars per share) $ 0.01 $ 0.01
Common stock, authorized (in Shares) 32,500,000 32,500,000
Common stock, issued (in Shares) 10,767,501 10,722,401
Common stock, outstanding (in Shares) 10,767,501 10,722,401
v3.26.1
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
CONDENSED STATEMENTS OF OPERATIONS [Abstract]        
Operating revenues $ 5,094,736 $ 5,009,370 $ 15,025,690 $ 14,751,845
Operating expenses:        
Data and product costs 2,191,789 2,205,871 6,669,223 6,566,750
Selling, general and administrative expenses 2,808,281 2,391,372 8,178,708 7,902,669
Depreciation and amortization 78,336 97,513 281,100 291,576
Total operating expenses 5,078,406 4,694,756 15,129,031 14,760,995
Income (loss) from operations 16,330 314,614 (103,341) (9,150)
Other income, net 164,256 249,185 475,921 619,800
Income before income taxes 180,586 563,799 372,580 610,650
Provision for income taxes (55,317) (176,650) (119,679) (279,838)
Net income $ 125,269 $ 387,149 $ 252,901 $ 330,812
Net income per share - Basic (in Dollars per share) $ 0.01 $ 0.04 $ 0.02 $ 0.03
Net income per share - Diluted (in Dollars per share) $ 0.01 $ 0.04 $ 0.02 $ 0.03
Weighted average number of common shares outstanding        
Basic (in Shares) 10,767,501 10,722,401 10,767,501 10,722,401
Diluted (in Shares) 10,848,607 10,770,383 10,852,979 10,764,587
v3.26.1
CONDENSED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2023 $ 107,224 $ 30,007,773 $ (21,364,928) $ 8,750,069
Balance (in Shares) at Dec. 31, 2023 10,722,401      
Net income $ 0 0 330,812 330,812
Stock-based compensation 0 73,892 0 73,892
Balance at Sep. 30, 2024 $ 107,224 30,081,665 (21,034,116) 9,154,773
Balance (in Shares) at Sep. 30, 2024 10,722,401      
Balance at Jun. 30, 2024 $ 107,224 30,055,386 (21,421,265) 8,741,345
Balance (in Shares) at Jun. 30, 2024 10,722,401      
Net income $ 0 0 387,149 387,149
Stock-based compensation 0 26,279 0 26,279
Balance at Sep. 30, 2024 $ 107,224 30,081,665 (21,034,116) 9,154,773
Balance (in Shares) at Sep. 30, 2024 10,722,401      
Balance at Dec. 31, 2024 $ 107,224 30,106,731 (20,058,335) $ 10,155,620
Balance (in Shares) at Dec. 31, 2024 10,722,401     10,722,401
Stock options exercised $ 451 96,484 0 $ 96,935
Stock options exercised (in Shares) 45,100      
Net income $ 0 0 252,901 252,901
Stock-based compensation 0 73,228 0 73,228
Balance at Sep. 30, 2025 $ 107,675 30,276,443 (19,805,434) $ 10,578,684
Balance (in Shares) at Sep. 30, 2025 10,767,501     10,767,501
Balance at Jun. 30, 2025 $ 107,675 30,253,683 (19,930,703) $ 10,430,655
Balance (in Shares) at Jun. 30, 2025 10,767,501      
Net income $ 0 0 125,269 125,269
Stock-based compensation 0 22,760 0 22,760
Balance at Sep. 30, 2025 $ 107,675 $ 30,276,443 $ (19,805,434) $ 10,578,684
Balance (in Shares) at Sep. 30, 2025 10,767,501     10,767,501
v3.26.1
CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net income $ 252,901 $ 330,812
Adjustments to reconcile net income to net cash provided by operating activities:    
Amortization of bond discount (131,190) (146,697)
Depreciation and amortization 281,100 291,576
Operating lease right-of-use asset, net 0 2,494
Stock-based compensation 73,228 73,892
Changes in operating assets and liabilities:    
Accounts receivable, net 654,353 375,116
Other current assets 29,773 (127,557)
Unexpired subscription revenue 20,652 709,902
Accounts payable (128,092) (69,066)
Accrued expenses 532,937 768,982
Net cash provided by operating activities 1,585,662 2,209,454
Cash flows from investing activities:    
Proceeds from held-to-maturity securities 2,695,000 2,850,000
Purchase of held-to-maturity securities (3,918,108) (7,898,319)
Purchase of property and equipment (215,573) (278,039)
Net cash used in investing activities (1,438,681) (5,326,358)
Cash flows from financing activities:    
Proceeds from exercise of stock options 96,935 0
Net cash provided by financing activities 96,935 0
Net increase (decrease) in cash and cash equivalents 243,916 (3,116,904)
Cash and cash equivalents at beginning of period 6,674,473 11,004,937
Cash and cash equivalents at end of period $ 6,918,389 $ 7,888,033
v3.26.1
Overview and Basis of Presentation
 9 Months Ended
Sep. 30, 2025
Overview and Basis of Presentation [Abstract]  
Overview and Basis of Presentation
(1) Overview and Basis of Presentation
 
CreditRiskMonitor.com, Inc. (the “Company” or “CreditRiskMonitor.com”) provides interactive business-to-business Software-as-a-Service (“SaaS”) subscription products designed specifically for credit and supply chain risk managers. These products are sold predominantly to corporations located in the United States.
 
The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Certain information and footnote disclosures required by generally accepted accounting principles (“GAAP”) in the United States for complete financial statements have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of management, the accompanying unaudited condensed financial statements reflect all material adjustments, including normal recurring accruals, necessary to present fairly the Company’s financial position, results of operations and cash flows for the periods presented, and have been prepared in a manner consistent with the audited financial statements for the fiscal year ended December 31, 2024 and Amendment No. 1 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2025.
 
The results of operations for the three and nine months ended September 30, 2025 and 2024 are not necessarily indicative of the results for an entire fiscal year.
 
The December 31, 2024 condensed balance sheet has been derived from the audited financial statements at that date, but does not include all disclosures required by GAAP. These condensed financial statements should be read in conjunction with the audited financial statements and the footnotes for the fiscal year ended December 31, 2024 included in the Company’s Annual Report on Form 10-K.
v3.26.1
Restatement of Previously Issued Financial Statements
 9 Months Ended
Sep. 30, 2025
Restatement of Previously Issued Financial Statements [Abstract]  
Restatement of Previously Issued Financial Statements
(2) Restatement of Previously Issued Financial Statements
 
In connection with a nexus study conducted with an external tax advisor, the Company’s management identified errors in previously issued financial statements. Management prepared a quantitative and qualitative analysis of the errors described below, in accordance with the SEC Staff's Accounting Bulletin ("SAB") Nos. 99 Materiality and No. 108, Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements, and concluded the aggregate impact of all the errors is material to the Company's previously reported financial statements as of and for the three and nine months ended September 30, 2025 and 2024. As a result, the Company’s management and the Audit Committee of the Company’s Board of Directors concluded that it is appropriate to restate the Company’s previously issued unaudited condensed financial statements as of and for the three and nine months ended September 30, 2025 and 2024, as previously reported in its Form 10-Q.
 
The accompanying condensed financial statements as of and for the three and nine months ended September 30, 2025 and 2024 have been restated from amounts previously reported. The restated classification and reported values of the errors noted from the nexus study are included in the condensed financial statements herein. The Company has also restated related amounts within the accompanying footnotes to the condensed financial statements to conform to the corrected amounts in the condensed financial statements.
 
Description of Restatement Errors
 
Based on a nexus study, the Company determined that it had economic and physical nexus in state and local jurisdictions where it historically had not been collecting and remitting sales and use tax and filing income taxes. As a result, the Company concluded that it had a historical state sales and use tax liability and income tax liability related to prior periods. The Company subsequently pursued Voluntary Disclosure Agreements (“VDAs”) to address this liability and to mitigate future exposure based on counsel of its tax advisor.
The liability includes an estimate for each state, to account for any interest that is due on the base tax amount owed. The error resulted in an understatement of accrued expenses for state and local sales tax and income tax, including related interest in the previously issued financial statements as of and for the three and nine months ended September 30, 2025 and 2024. As a result of correcting this liability, selling, general and administrative expenses; income tax expense; and interest expense were increased in the affected periods. The underlying sales tax obligations are appropriately recognized and the Company is in various stages of VDA review, submission, acceptance and payment with the states impacted. The Company has subsequently engaged an independent third-party provider of automated sales tax solutions to support with compliance through continuous identification, monitoring and evaluation of our transaction activity and physical presence.
 
Financial Statements - Restatement Reconciliation Tables
 
In accordance with Accounting Standards Codification ("ASC") 250, Accounting Changes and Error Corrections, the Company has corrected this error by restating previously issued financial statements.
 
The following tables summarize the effect of the restatement on each financial statement line item as of the dates, and for the periods indicated. The amounts in the "As Restated" columns are the updated amounts including the impacts from the restatement. Financial statement line items and subtotals that were not impacted by the restatement adjustments have been omitted for enhanced clarity.
 
Balance Sheet – as of December 31, 2024:
 
   
As Previously
Reported
    
Adjustment
   
As Restated
 
                
Accrued expenses
  $1,931,281   $1,260,238   $3,191,519 
Total current liabilities
   13,137,858    1,260,238    14,398,096 
Deferred tax liabilities, net
   481,420    (274,112)    207,308 
Total liabilities
   13,770,752    986,126    14,756,878 
                
Accumulated deficit
   (19,072,209)    (986,126)    (20,058,335) 
Total stockholders’ equity
  $11,141,746   $(986,126)   $10,155,620 
 
Balance Sheet – as of September 30, 2025:
 
   
As Previously
Reported
   
Adjustment
   
As Restated
 
                
Accrued expenses
  $2,083,662   $1,640,794   $3,724,456 
Total current liabilities
   13,199,789    1,640,794    14,840,583 
Deferred tax liabilities, net
   481,420    (274,112)    207,308 
Total liabilities
   13,921,470    1,366,682    15,288,152 
                
Accumulated deficit
   (18,438,752)    (1,366,682)    (19,805,434) 
Total stockholders’ equity
  $11,945,366   $(1,366,682)   $10,578,684 
Statement of Operations – Three Months Ended September 30, 2025:
 
   
As Previously
Reported
   
Adjustment
   
As Restated
 
                
Selling, general, and administrative expenses
  $2,697,192   $111,089   $2,808,281 
Total operating expenses
   4,967,317    111,089    5,078,406 
Income from operations
   127,419    (111,089)    16,330 
Other income, net
   193,222    (28,966)    164,256 
Income before income taxes
   320,641    (140,055)    180,586 
Provision for income taxes
   (75,773)    20,456    (55,317) 
Net income
   244,868    (119,599)    125,269 
                
Net income per share – Basic and diluted
  $0.02   $(0.01)   $0.01 
 
Statement of Operations – Three Months Ended September 30, 2024:
 
   
As Previously
Reported
   
Adjustment
   
As Restated
 
                
Selling, general, and administrative expenses
  $2,256,732   $134,640   $2,391,372 
Total operating expenses
   4,560,116    134,640    4,694,756 
Income from operations
   449,254    (134,640)    314,614 
Other income, net
   267,092    (17,907)    249,185 
Income before income taxes
   716,346    (152,547)    563,799 
Provision for income taxes
   (164,764)    (11,886)    (176,650) 
Net income
   551,582    (164,433)    387,149 
                
Net income per share – Basic and diluted
  $0.05   $(0.01)   $0.04 
 
Statement of Operations – Nine Months Ended September 30, 2025:
 
   
As Previously
Reported
   
Adjustment
   
As Restated
 
                
Selling, general, and administrative expenses
  $7,801,311   $377,397   $8,178,708 
Total operating expenses
   14,751,634    377,397    15,129,031 
Income (loss) from operations
   274,056    (377,397)    (103,341) 
Other income, net
   553,739    (77,818)    475,921 
Income before income taxes
   827,795    (455,215)    372,580 
Provision for income taxes
   (194,338)    74,659    (119,679) 
Net income
   633,457    (380,556)    252,901 
                
Net income per share – Basic and diluted
  $0.06   $(0.04)   $0.02 
Statement of Operations – Nine Months Ended September 30, 2024:
 
   
As Previously
Reported
   
Adjustment
   
As Restated
 
                
Selling, general, and administrative expenses
  $7,505,751   $396,918   $7,902,669 
Total operating expenses
   14,364,077    396,918    14,760,995 
Income (loss) from operations
   387,768    (396,918)    (9,150) 
Other income, net
   664,587    (44,787)    619,800 
Income before income taxes
   1,052,355    (441,705)    610,650 
Provision for income taxes
   (244,180)    (35,658)    (279,838) 
Net income
   808,175    (477,363)    330,812 
                
Net income per share – Basic and diluted
  $0.08   $(0.05)   $0.03 
 
Statements of Stockholders' Equity – Three Months Ended September 30, 2025:
 
   
As Previously
Reported
   
Adjustment
   
As Restated
 
                
Balance as of July 1, 2025
               
Accumulated deficit
  $(18,683,620)   $(1,247,083)   $(19,930,703) 
Total stockholders’ equity
   11,677,738    (1,247,083)    10,430,655 
                
Balance as of September 30, 2025
               
Accumulated deficit
  $(18,438,752)   $(1,366,682)   $(19,805,434) 
Total stockholders’ equity
   11,945,366    (1,366,682)    10,578,684 
 
Statements of Stockholders' Equity – Three Months Ended September 30, 2024:
 
   
As Previously
Reported
   
Adjustment
   
As Restated
 
                
Balance as of July 1, 2024
               
Accumulated deficit
  $(20,490,518)   $(930,747)   $(21,421,265) 
Total stockholders’ equity
   9,672,092    (930,747)    8,741,345 
                
Balance as of September 30, 2024
               
Accumulated deficit
  $(19,938,936)   $(1,095,180)   $(21,034,116) 
Total stockholders’ equity
   10,249,953    (1,095,180)    9,154,773 
 
Statements of Stockholders' Equity – Nine Months Ended September 30, 2025:
 
   
As Previously
Reported
   
Adjustment
   
As Restated
 
                
Balance as of January 1, 2025
               
Accumulated deficit
  $(19,072,209)   $(986,126)   $(20,058,335) 
Total stockholders’ equity
   11,141,746    (986,126)    10,155,620 
                
Balance as of September 30, 2025
               
Accumulated deficit
  $(18,438,752)   $(1,366,682)   $(19,805,434) 
Total stockholders’ equity
   11,945,366    (1,366,682)    10,578,684 
Statements of Stockholders' Equity – Nine Months Ended September 30, 2024:
 
   
As Previously
Reported
   
Adjustment
   
As Restated
 
                
Balance as of January 1, 2024
               
Accumulated deficit
  $(20,747,111)   $(617,817)   $(21,364,928) 
Total stockholders’ equity
   9,367,886    (617,817)    8,750,069 
                
Balance as of September 30, 2024
               
Accumulated deficit
  $(19,938,936)   $(1,095,180)   $(21,034,116) 
Total stockholders’ equity
   10,249,953    (1,095,180)    9,154,773 
 
Statements of Cash Flows – Nine Months Ended September 30, 2025:
 
   
As Previously
Reported
   
Adjustment
   
As Restated
 
                
Cash flows from operating activities:
               
Net income
  $633,457   $(380,556)   $252,901 
                
Changes in operating assets and liabilities:
               
Accrued expenses
   152,381    380,556    532,937 
 
Statements of Cash Flows – Nine Months Ended September 30, 2024:
 
   
As Previously
Reported
   
Adjustment
   
As Restated
 
                
Cash flows from operating activities:
               
Net income
  $808,175   $(477,363)   $330,812 
                
Changes in operating assets and liabilities:
               
Accrued expenses
   291,619    477,363    768,982 
v3.26.1
Recently Issued Accounting Standards
 9 Months Ended
Sep. 30, 2025
Recently Issued Accounting Standards [Abstract]  
Recently Issued Accounting Standards
(3) Recently Issued Accounting Standards
 
In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”). ASU 2023-07 expands public entities’ segment disclosures by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”) and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment. All disclosure requirements under ASU 2023-07 are also required for public entities with a single reportable segment. The Company adopted ASU 2023-07 on January 1, 2024 and the adoption of this update did not have a significant impact on the Company's financial statements (see Note 10).
 
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”), which provides for improvements to income tax disclosures primarily related to rate reconciliation and income taxes paid by jurisdiction. This guidance is effective for annual reporting periods beginning after December 15, 2024. The Company is currently evaluating the effects of this pronouncement on its financial statements.
 
In November 2024, the FASB issued ASU 2024-03, Income Statement–Reporting Comprehensive Income–Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (“ASU 2024-03”), to improve disclosures about a public entity’s expenses by requiring disclosure of additional information about the types of expenses commonly presented in the financial statements on an annual and interim basis. This guidance will be effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. The Company is currently evaluating the impact of adoption of this pronouncement on its financial statements.
v3.26.1
Revenue Recognition
 9 Months Ended
Sep. 30, 2025
Revenue Recognition [Abstract]  
Revenue Recognition
(4) Revenue Recognition
 
The Company applies FASB Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers (Topic 606) (“ASC 606”), to recognize revenue. ASC 606 requires an entity to apply the following five-step approach: (1) identify the contract(s) with a customer; (2) identify each performance obligation in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation; and (5) recognize revenue when or as each performance obligation is satisfied. The Company’s primary source of revenue is subscription income which is recognized ratably over the subscription term.
v3.26.1
Stockholders’ Equity
 9 Months Ended
Sep. 30, 2025
Stockholders’ Equity [Abstract]  
Stockholders’ Equity
(5) Stockholders’ Equity
 
Stock-Based Compensation
 
The Company applies ASC 718, Compensation–Stock Compensation (Topic 718) (“ASC 718”), to account for stock-based compensation.
 
The following table summarizes the stock-based compensation expense for stock options that was recorded in the Company’s results of operations in accordance with ASC 718 for the three and nine months ended September 30:
 
                             
    3 Months Ended
September 30, 		   9 Months Ended
September 30, 		 
    2025     2024     2025     2024  
                             
Data and product costs
  $ 6,906    $ 8,213    $ 24,993    $ 23,764 
Selling, general and administrative expenses
    15,854      18,066      48,235      50,128 
                             
    $ 22,760    $ 26,279    $ 73,228    $ 73,892 
 
Stock Options
 
On April 1, 2025, the Company issued 45,100 shares of common stock upon the exercise of stock options. The stock options had a weighted-average exercise price of $2.15 per share. The Company received cash proceeds totaling $96,935 in connection with the exercise of these stock options. The total intrinsic value of the stock options exercised during the three and nine months ended September 30, 2025 was approximately $20,325.
 
There were no stock options exercised during the three and nine months ended September 30, 2024.
v3.26.1
Fair Value Measurements
 9 Months Ended
Sep. 30, 2025
Fair Value Measurements [Abstract]  
Fair Value Measurements
(6) Fair Value Measurements
 
The Company’s cash, cash equivalents and marketable securities are stated at fair value. The carrying values of accounts receivable, other current assets, accounts payable, and accrued expenses approximates fair market value because of the short maturity of these financial instruments.
 
The Company’s cash equivalents are generally classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices.
 
All held-to-maturity securities as of September 30, 2025 and December 31, 2024 were U.S. Treasury securities. Investments in these government securities are based on quoted market prices in active markets, and are included in the Level 1 fair value hierarchy.
The tables below set forth the Company’s cash and cash equivalents, as well as marketable securities as of September 30, 2025 and December 31, 2024, respectively, which are measured at fair value on a recurring basis by level within the fair value hierarchy.
 
    September 30, 2025  
   
Level 1
   
Level 2
   
Level 3
   
Total
 
                             
Cash and cash equivalents
   $ 6,918,389    $ −    $ −    $ 6,918,389 
Held-to-maturity securities
     12,579,773        −        −      12,579,773 
    $ 19,498,162    $ −    $ −    $ 19,498,162 
 
    December 31, 2024  
   
Level 1
   
Level 2
   
Level 3
   
Total
 
                             
Cash and cash equivalents
   $ 6,674,473    $ −    $ −    $ 6,674,473 
Held-to-maturity securities
     11,225,475        −        −      11,225,475 
    $ 17,899,948    $ −    $ −    $ 17,899,948 
 
The Company did not hold financial assets and liabilities which were recorded at fair value in the Level 2 or 3 categories as of September 30, 2025 and December 31, 2024, respectively.
 
The preceding methods may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. Furthermore, although the Company believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.
v3.26.1
Marketable Securities
 9 Months Ended
Sep. 30, 2025
Marketable Securities [Abstract]  
Marketable Securities
(7) Marketable Securities
 
Based upon the Company’s intent and ability to hold its U.S. Treasury securities to maturity, such securities have been classified as held-to-maturity and are carried at amortized cost, which approximates fair market value. Maturities on these U.S. Treasury security holdings range from 19 to 25 months from the date of purchase. Accrued bond interest receivable as of September 30, 2025 and December 31, 2024 was $96,651 and $79,497, respectively.
 
The tables below summarize the Company’s cost and fair value of marketable securities as of September 30, 2025 and December 31, 2024:
 
                      
    September 30, 2025  
    Amortized Cost      Gross Unrealized Gain      Fair Value  
Held-to-maturity securities
                    
U.S. Treasury securities
  $ 12,579,773    $ 109,227    $ 12,689,000 
 
                      
    December 31, 2024  
      Amortized Cost      Gross Unrealized Gain      Fair Value  
                      
Held-to-maturity securities
                    
U.S. Treasury securities
  $ 11,225,475    $ 227,525    $ 11,453,000 
Maturities of marketable securities were as follows as of September 30, 2025 and December 31, 2024:
 
         
      September 30,
2025 		     December 31,
2024 		 
               
Held-to-maturity securities:
             
Due in one year or less
  $ 6,098,773    $ 2,467,475 
Due in 12 – 24 months
    6,481,000      8,758,000 
               
    $ 12,579,773    $ 11,225,475 
 
The Company’s investments in marketable securities consist of investments in U.S. Treasury securities. Market values were determined for each individual security in the investment portfolio.
 
Management evaluates securities for other-than-temporary impairment at least on an annual basis, and more frequently when economic or market concerns warrant such evaluation. Consideration is given to (1) the length of time and the extent to which the fair value has been less than cost, (2) the financial condition and near-term prospects of the issuer, and (3) the intent and ability of the Company to retain its investment in the issuer for a period of time sufficient to allow for any anticipated recovery in fair value. Management has determined that no other-than-temporary impairment exists as of September 30, 2025.
v3.26.1
Net Income per Share
 9 Months Ended
Sep. 30, 2025
Net Income per Share [Abstract]  
Net Income per Share
(8) Net Income per Share
 
Basic net income per share is based on the weighted average number of common shares outstanding. Diluted net income per share is based on the weighted average number of common shares outstanding and the dilutive effect of outstanding stock options.
 
                             
     3 Months Ended
September 30, 		     9 Months Ended
September 30, 		 
                             
     2025      2024      2025      2024  
                             
Weighted average common shares outstanding – basic
   10,767,501      10,722,401      10,767,501      10,722,401  
Potential shares exercisable under stock option plans
   279,348      255,500      311,033      257,133  
Less: Shares which could be repurchased under treasury stock method
   (198,242 )     (207,518 )     (225,555 )     (214,947 ) 
Weighted average common shares outstanding – diluted
   10,848,607      10,770,383      10,852,979      10,764,587  
 
For the three and nine months ended September 30, 2025, the computation of diluted net income per share excludes the effects of the assumed exercise of 568,900 and 536,900 options, respectively, since their inclusion would be anti-dilutive as their exercise prices were above the average market value.
 
For the three and nine months ended September 30, 2024, the computation of diluted net income per share excludes the effects of the assumed exercise of 590,550 and 615,050 options, respectively, since their inclusion would be anti-dilutive as their exercise prices were above the average market value.
v3.26.1
Commitments and Contingencies
 9 Months Ended
Sep. 30, 2025
Commitments and Contingencies [Abstract]  
Commitments and Contingencies
(9) Commitments and Contingencies
 
From time to time, the Company is involved in various legal proceedings arising in the ordinary course of business. The Company records a liability when it believes that a loss will be incurred and the amount of loss or range of loss can be reasonably estimated. Based on the currently available information, the Company does not believe that there are claims or legal proceedings that would have a material adverse effect on the business, or the condensed financial statements of the Company.
v3.26.1
Segment Reporting
 9 Months Ended
Sep. 30, 2025
Segment Reporting [Abstract]  
Segment Reporting
(10) Segment Reporting
 
The Company has a single operating and reportable segment: SaaS subscription products. This segment includes add-ons and enhancements that can only be accessed with an active base subscription to its SaaS subscription products. The products are used mainly by subscribers to analyze commercial financial risk for the purpose of extending trade credit, evaluating supply chains, and managing the counterparty risk associated with these relationships.
 
The Company’s CODM is its Chief Executive Officer and President. The CODM makes operating decisions, assesses performance and allocates resources using the entity-wide revenue and expense information reported on the Condensed Statements of Operations and the more detailed significant expense categories disclosed in the table below. The primary measure of segment profit is net income as reported on the Condensed Statements of Operations.
 
    3 Months Ended
September 30,		    
9 Months Ended
September 30,
  
   
2025
   
2024
   
2025
   
2024
 
   
(As Restated)
   
(As Restated)
   
(As Restated)
   
(As Restated)
 
                     
Segment operating revenues
  $5,094,736   $5,009,370   $15,025,690   $14,751,845 
                     
Less:
                    
Significant segment expenses
                    
Data and product costs
                    
Employee expenses
   1,340,869    1,388,724    4,232,159    4,230,657 
Data feed expenses
   553,166    493,249    1,605,034    1,466,307 
Hosting and computer services expenses
   100,794    78,107    246,034    187,858 
Other data and product costs
   196,960    245,791    585,996    681,928 
Data and product costs subtotal
   2,191,789    2,205,871    6,669,223    6,566,750 
                     
Selling, general and administrative expenses
                    
Employee expenses
   1,983,938    1,700,470    5,830,985    5,723,720 
Professional fee expenses
   326,141    157,442    634,688    474,926 
Marketing expenses (1)
   187,058    201,498    598,912    687,419 
Occupancy expenses (2)
   47,745    104,639    271,783    320,943 
Other general and administrative expenses
   263,399    227,323    842,340    695,661 
Selling, general and administrative expenses subtotal
   2,808,281    2,391,372    8,178,708    7,902,669 
                     
Other significant segment items
                    
Depreciation and amortization
   78,336    97,513    281,100    291,576 
Other (income), net
   (164,256)    (249,185)    (475,921)    (619,800) 
Provision for income taxes
   55,317    176,650    119,679    279,838 
                     
Segment net income
  $125,269   $387,149   $252,901   $330,812 
 
(1) Marketing expenses include vendors, trade show conferences, and promotional materials.
(2) Occupancy expenses include rent, utilities, repairs, and office supplies.
v3.26.1
Supplemental Disclosures of Noncash Investing and Financing Activities
 9 Months Ended
Sep. 30, 2025
Supplemental Disclosures of Noncash Investing and Financing Activities [Abstract]  
Supplemental Disclosures of Noncash Investing and Financing Activities
(11) Supplemental Disclosures of Noncash Investing and Financing Activities
 
For the nine months ended September 30, 2025, there was a noncash transfer of operating lease right-of-use assets obtained in exchange for lease liabilities in the amount of $114,463.
v3.26.1
Restatement of Previously Issued Financial Statements (Tables)
 9 Months Ended
Sep. 30, 2025
Restatement of Previously Issued Financial Statements [Abstract]  
Financial Statements - Restatement Reconciliation Tables
The following tables summarize the effect of the restatement on each financial statement line item as of the dates, and for the periods indicated. The amounts in the "As Restated" columns are the updated amounts including the impacts from the restatement. Financial statement line items and subtotals that were not impacted by the restatement adjustments have been omitted for enhanced clarity.
 
Balance Sheet – as of December 31, 2024:
 
   
As Previously
Reported
    
Adjustment
   
As Restated
 
                
Accrued expenses
  $1,931,281   $1,260,238   $3,191,519 
Total current liabilities
   13,137,858    1,260,238    14,398,096 
Deferred tax liabilities, net
   481,420    (274,112)    207,308 
Total liabilities
   13,770,752    986,126    14,756,878 
                
Accumulated deficit
   (19,072,209)    (986,126)    (20,058,335) 
Total stockholders’ equity
  $11,141,746   $(986,126)   $10,155,620 
 
Balance Sheet – as of September 30, 2025:
 
   
As Previously
Reported
   
Adjustment
   
As Restated
 
                
Accrued expenses
  $2,083,662   $1,640,794   $3,724,456 
Total current liabilities
   13,199,789    1,640,794    14,840,583 
Deferred tax liabilities, net
   481,420    (274,112)    207,308 
Total liabilities
   13,921,470    1,366,682    15,288,152 
                
Accumulated deficit
   (18,438,752)    (1,366,682)    (19,805,434) 
Total stockholders’ equity
  $11,945,366   $(1,366,682)   $10,578,684 
Statement of Operations – Three Months Ended September 30, 2025:
 
   
As Previously
Reported
   
Adjustment
   
As Restated
 
                
Selling, general, and administrative expenses
  $2,697,192   $111,089   $2,808,281 
Total operating expenses
   4,967,317    111,089    5,078,406 
Income from operations
   127,419    (111,089)    16,330 
Other income, net
   193,222    (28,966)    164,256 
Income before income taxes
   320,641    (140,055)    180,586 
Provision for income taxes
   (75,773)    20,456    (55,317) 
Net income
   244,868    (119,599)    125,269 
                
Net income per share – Basic and diluted
  $0.02   $(0.01)   $0.01 
 
Statement of Operations – Three Months Ended September 30, 2024:
 
   
As Previously
Reported
   
Adjustment
   
As Restated
 
                
Selling, general, and administrative expenses
  $2,256,732   $134,640   $2,391,372 
Total operating expenses
   4,560,116    134,640    4,694,756 
Income from operations
   449,254    (134,640)    314,614 
Other income, net
   267,092    (17,907)    249,185 
Income before income taxes
   716,346    (152,547)    563,799 
Provision for income taxes
   (164,764)    (11,886)    (176,650) 
Net income
   551,582    (164,433)    387,149 
                
Net income per share – Basic and diluted
  $0.05   $(0.01)   $0.04 
 
Statement of Operations – Nine Months Ended September 30, 2025:
 
   
As Previously
Reported
   
Adjustment
   
As Restated
 
                
Selling, general, and administrative expenses
  $7,801,311   $377,397   $8,178,708 
Total operating expenses
   14,751,634    377,397    15,129,031 
Income (loss) from operations
   274,056    (377,397)    (103,341) 
Other income, net
   553,739    (77,818)    475,921 
Income before income taxes
   827,795    (455,215)    372,580 
Provision for income taxes
   (194,338)    74,659    (119,679) 
Net income
   633,457    (380,556)    252,901 
                
Net income per share – Basic and diluted
  $0.06   $(0.04)   $0.02 
Statement of Operations – Nine Months Ended September 30, 2024:
 
   
As Previously
Reported
   
Adjustment
   
As Restated
 
                
Selling, general, and administrative expenses
  $7,505,751   $396,918   $7,902,669 
Total operating expenses
   14,364,077    396,918    14,760,995 
Income (loss) from operations
   387,768    (396,918)    (9,150) 
Other income, net
   664,587    (44,787)    619,800 
Income before income taxes
   1,052,355    (441,705)    610,650 
Provision for income taxes
   (244,180)    (35,658)    (279,838) 
Net income
   808,175    (477,363)    330,812 
                
Net income per share – Basic and diluted
  $0.08   $(0.05)   $0.03 
 
Statements of Stockholders' Equity – Three Months Ended September 30, 2025:
 
   
As Previously
Reported
   
Adjustment
   
As Restated
 
                
Balance as of July 1, 2025
               
Accumulated deficit
  $(18,683,620)   $(1,247,083)   $(19,930,703) 
Total stockholders’ equity
   11,677,738    (1,247,083)    10,430,655 
                
Balance as of September 30, 2025
               
Accumulated deficit
  $(18,438,752)   $(1,366,682)   $(19,805,434) 
Total stockholders’ equity
   11,945,366    (1,366,682)    10,578,684 
 
Statements of Stockholders' Equity – Three Months Ended September 30, 2024:
 
   
As Previously
Reported
   
Adjustment
   
As Restated
 
                
Balance as of July 1, 2024
               
Accumulated deficit
  $(20,490,518)   $(930,747)   $(21,421,265) 
Total stockholders’ equity
   9,672,092    (930,747)    8,741,345 
                
Balance as of September 30, 2024
               
Accumulated deficit
  $(19,938,936)   $(1,095,180)   $(21,034,116) 
Total stockholders’ equity
   10,249,953    (1,095,180)    9,154,773 
 
Statements of Stockholders' Equity – Nine Months Ended September 30, 2025:
 
   
As Previously
Reported
   
Adjustment
   
As Restated
 
                
Balance as of January 1, 2025
               
Accumulated deficit
  $(19,072,209)   $(986,126)   $(20,058,335) 
Total stockholders’ equity
   11,141,746    (986,126)    10,155,620 
                
Balance as of September 30, 2025
               
Accumulated deficit
  $(18,438,752)   $(1,366,682)   $(19,805,434) 
Total stockholders’ equity
   11,945,366    (1,366,682)    10,578,684 
Statements of Stockholders' Equity – Nine Months Ended September 30, 2024:
 
   
As Previously
Reported
   
Adjustment
   
As Restated
 
                
Balance as of January 1, 2024
               
Accumulated deficit
  $(20,747,111)   $(617,817)   $(21,364,928) 
Total stockholders’ equity
   9,367,886    (617,817)    8,750,069 
                
Balance as of September 30, 2024
               
Accumulated deficit
  $(19,938,936)   $(1,095,180)   $(21,034,116) 
Total stockholders’ equity
   10,249,953    (1,095,180)    9,154,773 
 
Statements of Cash Flows – Nine Months Ended September 30, 2025:
 
   
As Previously
Reported
   
Adjustment
   
As Restated
 
                
Cash flows from operating activities:
               
Net income
  $633,457   $(380,556)   $252,901 
                
Changes in operating assets and liabilities:
               
Accrued expenses
   152,381    380,556    532,937 
 
Statements of Cash Flows – Nine Months Ended September 30, 2024:
 
   
As Previously
Reported
   
Adjustment
   
As Restated
 
                
Cash flows from operating activities:
               
Net income
  $808,175   $(477,363)   $330,812 
                
Changes in operating assets and liabilities:
               
Accrued expenses
   291,619    477,363    768,982 
v3.26.1
Stockholders’ Equity (Tables)
 9 Months Ended
Sep. 30, 2025
Stockholders’ Equity [Abstract]  
Stock-based Compensation Expense for Stock Options
The following table summarizes the stock-based compensation expense for stock options that was recorded in the Company’s results of operations in accordance with ASC 718 for the three and nine months ended September 30:
 
                             
    3 Months Ended
September 30, 		   9 Months Ended
September 30, 		 
    2025     2024     2025     2024  
                             
Data and product costs
  $ 6,906    $ 8,213    $ 24,993    $ 23,764 
Selling, general and administrative expenses
    15,854      18,066      48,235      50,128 
                             
    $ 22,760    $ 26,279    $ 73,228    $ 73,892 
v3.26.1
Fair Value Measurements (Tables)
 9 Months Ended
Sep. 30, 2025
Fair Value Measurements [Abstract]  
Cash and Cash Equivalents and Marketable Securities Measured at Fair Value on Recurring Basis
The tables below set forth the Company’s cash and cash equivalents, as well as marketable securities as of September 30, 2025 and December 31, 2024, respectively, which are measured at fair value on a recurring basis by level within the fair value hierarchy.
 
    September 30, 2025  
   
Level 1
   
Level 2
   
Level 3
   
Total
 
                             
Cash and cash equivalents
   $ 6,918,389    $ −    $ −    $ 6,918,389 
Held-to-maturity securities
     12,579,773        −        −      12,579,773 
    $ 19,498,162    $ −    $ −    $ 19,498,162 
 
    December 31, 2024  
   
Level 1
   
Level 2
   
Level 3
   
Total
 
                             
Cash and cash equivalents
   $ 6,674,473    $ −    $ −    $ 6,674,473 
Held-to-maturity securities
     11,225,475        −        −      11,225,475 
    $ 17,899,948    $ −    $ −    $ 17,899,948 
v3.26.1
Marketable Securities (Tables)
 9 Months Ended
Sep. 30, 2025
Marketable Securities [Abstract]  
Cost and Fair Value of Marketable Securities
The tables below summarize the Company’s cost and fair value of marketable securities as of September 30, 2025 and December 31, 2024:
 
                      
    September 30, 2025  
    Amortized Cost      Gross Unrealized Gain      Fair Value  
Held-to-maturity securities
                    
U.S. Treasury securities
  $ 12,579,773    $ 109,227    $ 12,689,000 
 
                      
    December 31, 2024  
      Amortized Cost      Gross Unrealized Gain      Fair Value  
                      
Held-to-maturity securities
                    
U.S. Treasury securities
  $ 11,225,475    $ 227,525    $ 11,453,000 
Maturities of Marketable Securities
Maturities of marketable securities were as follows as of September 30, 2025 and December 31, 2024:
 
         
      September 30,
2025 		     December 31,
2024 		 
               
Held-to-maturity securities:
             
Due in one year or less
  $ 6,098,773    $ 2,467,475 
Due in 12 – 24 months
    6,481,000      8,758,000 
               
    $ 12,579,773    $ 11,225,475 
v3.26.1
Net Income per Share (Tables)
 9 Months Ended
Sep. 30, 2025
Net Income per Share [Abstract]  
Computation of Basic and Diluted Net Income per Share
Basic net income per share is based on the weighted average number of common shares outstanding. Diluted net income per share is based on the weighted average number of common shares outstanding and the dilutive effect of outstanding stock options.
 
                             
     3 Months Ended
September 30, 		     9 Months Ended
September 30, 		 
                             
     2025      2024      2025      2024  
                             
Weighted average common shares outstanding – basic
   10,767,501      10,722,401      10,767,501      10,722,401  
Potential shares exercisable under stock option plans
   279,348      255,500      311,033      257,133  
Less: Shares which could be repurchased under treasury stock method
   (198,242 )     (207,518 )     (225,555 )     (214,947 ) 
Weighted average common shares outstanding – diluted
   10,848,607      10,770,383      10,852,979      10,764,587  
v3.26.1
Segment Reporting (Tables)
 9 Months Ended
Sep. 30, 2025
Segment Reporting [Abstract]  
Segment Financial Information of Reportable Segments The Company’s CODM is its Chief Executive Officer and President. The CODM makes operating decisions, assesses performance and allocates resources using the entity-wide revenue and expense information reported on the Condensed Statements of Operations and the more detailed significant expense categories disclosed in the table below. The primary measure of segment profit is net income as reported on the Condensed Statements of Operations
    3 Months Ended
September 30,		    
9 Months Ended
September 30,
  
   
2025
   
2024
   
2025
   
2024
 
   
(As Restated)
   
(As Restated)
   
(As Restated)
   
(As Restated)
 
                     
Segment operating revenues
  $5,094,736   $5,009,370   $15,025,690   $14,751,845 
                     
Less:
                    
Significant segment expenses
                    
Data and product costs
                    
Employee expenses
   1,340,869    1,388,724    4,232,159    4,230,657 
Data feed expenses
   553,166    493,249    1,605,034    1,466,307 
Hosting and computer services expenses
   100,794    78,107    246,034    187,858 
Other data and product costs
   196,960    245,791    585,996    681,928 
Data and product costs subtotal
   2,191,789    2,205,871    6,669,223    6,566,750 
                     
Selling, general and administrative expenses
                    
Employee expenses
   1,983,938    1,700,470    5,830,985    5,723,720 
Professional fee expenses
   326,141    157,442    634,688    474,926 
Marketing expenses (1)
   187,058    201,498    598,912    687,419 
Occupancy expenses (2)
   47,745    104,639    271,783    320,943 
Other general and administrative expenses
   263,399    227,323    842,340    695,661 
Selling, general and administrative expenses subtotal
   2,808,281    2,391,372    8,178,708    7,902,669 
                     
Other significant segment items
                    
Depreciation and amortization
   78,336    97,513    281,100    291,576 
Other (income), net
   (164,256)    (249,185)    (475,921)    (619,800) 
Provision for income taxes
   55,317    176,650    119,679    279,838 
                     
Segment net income
  $125,269   $387,149   $252,901   $330,812 
 
(1) Marketing expenses include vendors, trade show conferences, and promotional materials.
(2) Occupancy expenses include rent, utilities, repairs, and office supplies.
v3.26.1
Restatement of Previously Issued Financial Statements - Financial Statements - Restatement Reconciliation Tables (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Restatement of Previously Issued Financial Statements [Abstract]          
Accrued expenses $ 3,724,456   $ 3,724,456   $ 3,191,519
Total current liabilities 14,840,583   14,840,583   14,398,096
Deferred tax liabilities, net 207,308   207,308   207,308
Total liabilities 15,288,152   15,288,152   14,756,878
Accumulated deficit (19,805,434) $ (21,034,116) (19,805,434) $ (21,034,116) (20,058,335)
Total stockholders’ equity 10,578,684 9,154,773 10,578,684 9,154,773 10,155,620
Selling, general, and administrative expenses 2,808,281 2,391,372 8,178,708 7,902,669  
Total operating expenses 5,078,406 4,694,756 15,129,031 14,760,995  
Income (loss) from operations 16,330 314,614 (103,341) (9,150)  
Other income, net 164,256 249,185 475,921 619,800  
Income before income taxes 180,586 563,799 372,580 610,650  
Provision for income taxes (55,317) (176,650) (119,679) (279,838)  
Net income $ 125,269 $ 387,149 $ 252,901 $ 330,812  
Net income per share - Basic (in Dollars per share) $ 0.01 $ 0.04 $ 0.02 $ 0.03  
Net income per share - Diluted (in Dollars per share) $ 0.01 $ 0.04 $ 0.02 $ 0.03  
Accumulated deficit $ (19,930,703) $ (21,421,265) $ (20,058,335) $ (21,364,928)  
Balance 10,430,655 8,741,345 10,155,620 8,750,069  
Accumulated deficit (19,805,434) (21,034,116) (19,805,434) (21,034,116)  
Balance 10,578,684 9,154,773 10,578,684 9,154,773  
Cash flows from operating activities:          
Net income 125,269 387,149 252,901 330,812  
Changes in operating assets and liabilities:          
Accrued expenses     532,937 768,982  
As Previously Reported [Member]          
Restatement of Previously Issued Financial Statements [Abstract]          
Accrued expenses 2,083,662   2,083,662   1,931,281
Total current liabilities 13,199,789   13,199,789   13,137,858
Deferred tax liabilities, net 481,420   481,420   481,420
Total liabilities 13,921,470   13,921,470   13,770,752
Accumulated deficit (18,438,752) (19,938,936) (18,438,752) (19,938,936) (19,072,209)
Total stockholders’ equity 11,945,366 10,249,953 11,945,366 10,249,953 11,141,746
Selling, general, and administrative expenses 2,697,192 2,256,732 7,801,311 7,505,751  
Total operating expenses 4,967,317 4,560,116 14,751,634 14,364,077  
Income (loss) from operations 127,419 449,254 274,056 387,768  
Other income, net 193,222 267,092 553,739 664,587  
Income before income taxes 320,641 716,346 827,795 1,052,355  
Provision for income taxes (75,773) (164,764) (194,338) (244,180)  
Net income $ 244,868 $ 551,582 $ 633,457 $ 808,175  
Net income per share - Basic (in Dollars per share) $ 0.02 $ 0.05 $ 0.06 $ 0.08  
Net income per share - Diluted (in Dollars per share) $ 0.02 $ 0.05 $ 0.06 $ 0.08  
Accumulated deficit $ (18,683,620) $ (20,490,518) $ (19,072,209) $ (20,747,111)  
Balance 11,677,738 9,672,092 11,141,746 9,367,886  
Accumulated deficit (18,438,752) (19,938,936) (18,438,752) (19,938,936)  
Balance 11,945,366 10,249,953 11,945,366 10,249,953  
Cash flows from operating activities:          
Net income 244,868 551,582 633,457 808,175  
Changes in operating assets and liabilities:          
Accrued expenses     152,381 291,619  
Adjustment [Member]          
Restatement of Previously Issued Financial Statements [Abstract]          
Accrued expenses 1,640,794   1,640,794   1,260,238
Total current liabilities 1,640,794   1,640,794   1,260,238
Deferred tax liabilities, net (274,112)   (274,112)   (274,112)
Total liabilities 1,366,682   1,366,682   986,126
Accumulated deficit (1,366,682) (1,095,180) (1,366,682) (1,095,180) (986,126)
Total stockholders’ equity (1,366,682) (1,095,180) (1,366,682) (1,095,180) $ (986,126)
Selling, general, and administrative expenses 111,089 134,640 377,397 396,918  
Total operating expenses 111,089 134,640 377,397 396,918  
Income (loss) from operations (111,089) (134,640) (377,397) (396,918)  
Other income, net (28,966) (17,907) (77,818) (44,787)  
Income before income taxes (140,055) (152,547) (455,215) (441,705)  
Provision for income taxes 20,456 (11,886) 74,659 (35,658)  
Net income $ (119,599) $ (164,433) $ (380,556) $ (477,363)  
Net income per share - Basic (in Dollars per share) $ (0.01) $ (0.01) $ (0.04) $ (0.05)  
Net income per share - Diluted (in Dollars per share) $ (0.01) $ (0.01) $ (0.04) $ (0.05)  
Accumulated deficit $ (1,247,083) $ (930,747) $ (986,126) $ (617,817)  
Balance (1,247,083) (930,747) (986,126) (617,817)  
Accumulated deficit (1,366,682) (1,095,180) (1,366,682) (1,095,180)  
Balance (1,366,682) (1,095,180) (1,366,682) (1,095,180)  
Cash flows from operating activities:          
Net income $ (119,599) $ (164,433) (380,556) (477,363)  
Changes in operating assets and liabilities:          
Accrued expenses     $ 380,556 $ 477,363  
v3.26.1
Stockholders’ Equity (Details) - Stock Options [Member] - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Jun. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Stockholders’ Equity [Abstract]          
Shares of common stock exercise (in Shares)   45,100 0   0
Exercise price (in Dollars per share)   $ 2.15      
Proceeds from exercise of stock options   $ 96,935      
Intrinsic value of stock options exercised $ 20,325     $ 20,325  
v3.26.1
Stockholders’ Equity - Stock-based Compensation Expense for Stock Options (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Stockholders’ Equity [Abstract]        
Stock-based compensation expense $ 22,760 $ 26,279 $ 73,228 $ 73,892
Data and Product Costs [Member]        
Stockholders’ Equity [Abstract]        
Stock-based compensation expense 6,906 8,213 24,993 23,764
Selling, General and Administrative Expenses [Member]        
Stockholders’ Equity [Abstract]        
Stock-based compensation expense $ 15,854 $ 18,066 $ 48,235 $ 50,128
v3.26.1
Fair Value Measurements - Cash and Cash Equivalents and Marketable Securities Measured at Fair Value on Recurring Basis (Details) - Recurring [Member] - USD ($)
Sep. 30, 2025
Dec. 31, 2024
Fair Value Measurements [Abstract]    
Cash and cash equivalents $ 6,918,389 $ 6,674,473
Held-to-maturity securities 12,579,773 11,225,475
Fair Value 19,498,162 17,899,948
Level 1 [Member]    
Fair Value Measurements [Abstract]    
Cash and cash equivalents 6,918,389 6,674,473
Held-to-maturity securities 12,579,773 11,225,475
Fair Value 19,498,162 17,899,948
Level 2 [Member]    
Fair Value Measurements [Abstract]    
Cash and cash equivalents 0 0
Held-to-maturity securities 0 0
Fair Value 0 0
Level 3 [Member]    
Fair Value Measurements [Abstract]    
Cash and cash equivalents 0 0
Held-to-maturity securities 0 0
Fair Value $ 0 $ 0
v3.26.1
Marketable Securities (Details) - USD ($)
 9 Months Ended
Sep. 30, 2025
Dec. 31, 2024
Marketable Securities [Abstract]    
Accrued bond interest receivable $ 96,651 $ 79,497
Other-than-temporary impairment loss $ 0  
v3.26.1
Marketable Securities - Cost and Fair Value of Marketable Securities (Details) - USD ($)
Sep. 30, 2025
Dec. 31, 2024
Held-to-maturity securities    
Amortized Cost $ 12,579,773 $ 11,225,475
Gross Unrealized Gain 109,227 227,525
Fair Value $ 12,689,000 $ 11,453,000
v3.26.1
Marketable Securities - Maturities of Marketable Securities (Details) - USD ($)
Sep. 30, 2025
Dec. 31, 2024
Held-to-maturity securities:    
Due in one year or less $ 6,098,773 $ 2,467,475
Due in 12 – 24 months 6,481,000 8,758,000
Held-to-maturity securities $ 12,579,773 $ 11,225,475
v3.26.1
Net Income per Share (Details) - shares
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Stock Options [Member]        
Net Income per Share [Abstract]        
Antidilutive securities excluded from computation of earnings per share (in Shares) 568,900 590,550 536,900 615,050
v3.26.1
Net Income per Share - Computation of Basic and Diluted Net Income per Share (Details) - shares
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Net Income per Share [Abstract]        
Weighted average common shares outstanding – basic (in Shares) 10,767,501 10,722,401 10,767,501 10,722,401
Potential shares exercisable under stock option plans (in Shares) 279,348 255,500 311,033 257,133
Less: Shares which could be repurchased under treasury stock method (in Shares) (198,242) (207,518) (225,555) (214,947)
Weighted average common shares outstanding – diluted (in Shares) 10,848,607 10,770,383 10,852,979 10,764,587
v3.26.1
Segment Reporting (Details)
 9 Months Ended
Sep. 30, 2025
Segment
Segment Reporting [Abstract]  
Number of operating segments 1
Number of reportable segments 1
v3.26.1
Segment Reporting - Segment Financial Information of Reportable Segments (Details) - Single Reportable Segment [Member[ - Operating Segment [Member] - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Segment Reporting [Abstract]        
Segment operating revenues $ 5,094,736 $ 5,009,370 $ 15,025,690 $ 14,751,845
Data and product costs        
Employee expenses 1,340,869 1,388,724 4,232,159 4,230,657
Data feed expenses 553,166 493,249 1,605,034 1,466,307
Hosting and computer services expenses 100,794 78,107 246,034 187,858
Other data and product costs 196,960 245,791 585,996 681,928
Data and product costs subtotal 2,191,789 2,205,871 6,669,223 6,566,750
Selling, general and administrative expenses        
Employee expenses 1,983,938 1,700,470 5,830,985 5,723,720
Professional fee expenses 326,141 157,442 634,688 474,926
Marketing expenses [1] 187,058 201,498 598,912 687,419
Occupancy expenses [2] 47,745 104,639 271,783 320,943
Other general and administrative expenses 263,399 227,323 842,340 695,661
Selling, general and administrative expenses subtotal 2,808,281 2,391,372 8,178,708 7,902,669
Other significant segment items        
Depreciation and amortization 78,336 97,513 281,100 291,576
Other (income), net (164,256) (249,185) (475,921) (619,800)
Provision for income taxes 55,317 176,650 119,679 279,838
Net income $ 125,269 $ 387,149 $ 252,901 $ 330,812
[1] Marketing expenses include vendors, trade show conferences, and promotional materials.
[2] Occupancy expenses include rent, utilities, repairs, and office supplies.
v3.26.1
Supplemental Disclosures of Noncash Investing and Financing Activities (Details)
 9 Months Ended
Sep. 30, 2025
USD ($)
Supplemental Disclosures of Noncash Investing and Financing Activities [Abstract]  
Operating lease right-of-use assets obtained in exchange for lease liabilities $ 114,463